The co-morbidity of diabetes and tuberculosis poses a significant challenge to public health systems globally. Because diabetes mellitus increases the risk of mortality and treatment failure, integrated diabetes screening in TB patients is essential. A recent study in Burundi has highlighted the feasibility and outcomes of such systematic screening programs in resource-limited settings.

In this study, researchers assessed 324 individuals diagnosed with tuberculosis. Among these patients, the prevalence of diabetes was 6.8%. Furthermore, the "number needed to test" (NNT) to identify a single case was 15, which indicates high efficiency. Predictors of diabetes included a positive family history, tobacco consumption, and unemployment. Consequently, the findings support the integration of metabolic screening within TB treatment centers.

Benefits of Integrated Diabetes Screening in TB Care

Implementing systematic screening requires specific enablers such as healthcare worker training and free-of-charge testing. Moreover, providing diabetes treatment at the same point of care as TB therapy improves patient adherence. However, clinicians must address remaining logistical challenges to ensure a successful national rollout. In India, the National Framework for Joint Management of TB-DM already provides a roadmap for such collaborative activities. Therefore, adopting these integrated models can significantly reduce the dual burden of these diseases.

FAQs

Why is it necessary to screen TB patients for diabetes?

Diabetes impairs the immune system, leading to higher rates of TB treatment failure and relapse. Therefore, early detection through systematic screening helps clinicians manage both conditions simultaneously, improving patient survival.

What are the primary predictors for diabetes in TB patients?

Key predictors identified in clinical studies include a positive family history of diabetes, tobacco use, and certain socioeconomic factors like unemployment. Consequently, screening these high-risk groups can be a cost-effective strategy.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Ciza F et al. Feasibility and outcomes of diabetes mellitus screening in people with tuberculosis in Burundi. Int Health. 2026 Apr 23. doi: undefined. PMID: 42023469.


2. Viswanathan V, et al. Management of diabetes and tuberculosis: A review. J Diabetol. 2022;13:1-10.


3. Ministry of Health and Family Welfare (India). National Framework for Joint Management of Tuberculosis and Diabetes. Central TB Division, 2017.